TY - JOUR T1 - Digitising point of care HIV test results to accurately measure, and improve performance towards, the UNAIDS 90-90-90 targets JF - medRxiv DO - 10.1101/19012302 SP - 19012302 AU - Nisha Jacob AU - Brian Rice AU - Emma Kalk AU - Alexa Heekes AU - Jennie Morgan AU - James Hargreaves AU - Andrew Boulle Y1 - 2019/01/01 UR - http://medrxiv.org/content/early/2019/11/15/19012302.abstract N2 - Introduction High rates of pre-treatment loss to care among persons diagnosed with HIV persist. Linkage to care can be improved through active digitally-based surveillance. Currently, record-keeping for HIV diagnoses in South Africa is paper-based. Aggregated testing data are reported routinely, and only discordant findings result in a specimen being tested at a laboratory and digitised.Methods The Western Cape Province in South Africa has a Provincial Health Data Centre (PHDC) where person-level routine data are consolidated in a single database, leveraging the existence of a unique patient identifier. To facilitate improved surveillance, a pre-carbonated point-of-care test (PoCT) form was piloted, where one copy was routed to the centralised laboratory and digitised for PHDC inclusion. We evaluated the utility of the intervention using cross-sectional and retrospective cohort analyses, as well as comparisons with reported aggregate data.Results From May 2017 to June 2018, 11337 digitised point-of-care HIV testing records were linked to the PHDC. Overall, 96% of records in the aggregate dataset were digitised, with 97% linked to the PHDC. Of those tested, 79% were female (median age 27 years). Linkage demonstrated that 51.3% of patients testing HIV-positive were retesting. Of those truly newly diagnosed, 81% were linked to HIV care and 25% were initiated on antiretroviral therapy immediately.Conclusion Digitisation of PoCT results is feasible and provides individuated HIV testing data to assist in linkage to care and in differentiating newly diagnosed patients from positive patients retesting. Actionable and accurate data can improve the measurement of performance towards the UNAIDS 90-90-90 targets.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe gratefully acknowledge our funders: Bill and Melinda Gates Foundation OPP1120138 (grant recipient: James Hargreaves), OPP1164272 (grant recepient: Andrew Boulle) and the National Institutes of Health; R01 HD080465 (grant recipient: Andrew Boulle), U01 AI069924.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are not made available as they are unconsented, de-identified routine administrative data housed in the Western Cape Provincial Health Data Centre. ER -